Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
Produces pharmaceutical products including doxopin hydrochloride, chlorprothixene and phenoxy benzamine and other intermediates. Company profile, and product and contact details.